The global forskolin market size reached USD 559.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,061.0 Million by 2033, exhibiting a growth rate (CAGR) of 7.01% during 2025-2033. The escalating demand for herbal and ayurvedic products, growing usage of forskolin in cosmetics and personal care items, and increasing product applications in foods and beverages represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 559.0 Million |
Market Forecast in 2033 | USD 1,061.0 Million |
Market Growth Rate 2025-2033 | 7.01% |
Forskolin is a labdane diterpenoid obtained from the roots of the Indian Coleus plant, which is a tropical plant related to mint. It is a natural active compound used as a plant metabolite, an anti-HIV agent, a protein kinase A agonist, an adenylate cyclase agonist, an antihypertensive agent, and a platelet aggregation inhibitor. It offers antihypertensive, positive ionotropic, smooth muscle relaxant, and platelet aggregation inhibitory properties. It also helps reduce intraocular pressure and stimulates the release of hormones from the pituitary gland. It has a long history of use in traditional Ayurvedic medicine. It is known to promote weight loss, lower high blood pressure, and treat glaucoma, heart diseases, and asthma. As a result, forskolin finds extensive applications in the formulation of dietary supplements and herbal medicines.
In recent years, there has been a substantial shift among the masses from synthetically processed ingredients toward naturally derived, herbal, and ayurvedic products. This, coupled with the rising usage of forskolin in the production of medicines, healthcare, and fitness products due to its high medicinal value, represents one of the key factors driving the market growth. Moreover, the growing adoption of high-purity forskolin in manufacturing cosmetics and skincare items as a conditioning agent has augmented the product demand. Additionally, the increasing preference for natural ingredients with active properties, such as anti-aging, in personal care products has catalyzed market growth. This is further strengthened by the aging population, growing consciousness regarding personal appearance, improving lifestyles, and elevating social media influence. In line with this, the escalating demand for dietary supplements owing to the widespread prevalence of lifestyle diseases, including obesity, high blood pressure, and cardiovascular disorders, has propelled market growth. Furthermore, the leading manufacturers are focusing on the development of forskolin sustainably with high-speed innovations in synthetic biology. In line with this, continual technological advancements in production processes and new product launches are contributing to market growth. Other factors, including the expanding pharmaceutical industry, increasing product applications in food and beverages, inflating consumer disposable incomes, and extensive research and development (R&D) activities, are also creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each segment of the global forskolin market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on concentration and end use.
Concentration Insights:
The report has provided a detailed breakup and analysis of the forskolin market based on the concentration. This includes low concentration (10%), medium concentration (20%-40%), and high concentration (95%). According to the report, high concentration (95%) represented the largest segment.
End Use Insights:
A detailed breakup and analysis of the forskolin market based on the end use has also been provided in the report. This includes nutraceuticals, pharmaceuticals, dietary supplements, and others. According to the report, dietary supplements accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
The report has also provided a comprehensive analysis of the competitive landscape in the global forskolin market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alchem International Pvt. Ltd., Alpspure Lifesciences Pvt. Ltd., Bioprex Labs, Cymbio Pharma Pvt Ltd, Flavour Trove, Glentham Life Sciences Limited, Nutra Green Biotechnology Co. Ltd., Sabinsa Corporation, Varion Lifesciences Pvt. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Concentrations Covered | Low Concentration (10%), Medium Concentration (20%-40%), High Concentration (95%) |
End Uses Covered | Nutraceuticals, Pharmaceuticals, Dietary Supplements, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Alchem International Pvt. Ltd., Alpspure Lifesciences Pvt. Ltd., Bioprex Labs, Cymbio Pharma Pvt Ltd, Flavour Trove, Glentham Life Sciences Limited, Nutra Green Biotechnology Co. Ltd., Sabinsa Corporation, Varion Lifesciences Pvt. Ltd., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |